Saudi Arabia vs Singapore: Protecting minority investors: Strength of minority investor
Saudi Arabia
43 DB15-20 methodology
in 2019
Singapore
43 DB15-20 methodology
in 2019
Saudi Arabia rank
3rd
Singapore rank
3rd
Protecting minority investors: Strength of minority investor over time
- Saudi Arabia
- Singapore
How they compare
Saudi Arabia currently reports 43 DB15-20 methodology against 43 DB15-20 methodology in Singapore, a difference of 0 DB15-20 methodology.
Across all 7 years both countries report, Singapore has been ahead every year.
Saudi Arabia ranks 3rd and Singapore ranks 3rd of 191 countries.
Singapore has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, Saudi Arabia or Singapore?
- Saudi Arabia, at 43 DB15-20 methodology against 43 DB15-20 methodology in Singapore as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between Saudi Arabia and Singapore?
- 0 DB15-20 methodology, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Singapore?
- 7 years are reported by both, from 2013 to 2019.
- How do Saudi Arabia and Singapore rank globally for protecting minority investors: strength of minority investor?
- Saudi Arabia ranks 3rd and Singapore ranks 3rd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.